At 21.5% CAGR, CBD Oil Market Size & Share | Cannabidiol Oil Industry Report, 2020-2025 | Covid-19 Impact Analysis

In its latest report on CBD Oil Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players. Cannabidiol Oil (CBD Oil) Market: Global Market Size, Read the full article…

What is CBD Isolate, And How Is It Used?

As CBD continues to gain massive popularity across the globe, its fanatic fans don’t shy away from coming up with interesting ways to consume it. Luckily, CBD stands concrete with a market worth of over $1 billion, which is expected to cross the $5 billion mark near future. If you’re looking for one of the Read the full article…

FDA Advances Work Related To Cannabidiol Products With Focus On Protecting Public Health, Providing Market Clarity

DISTRICT OF COLUMBIA: Over the past year, the U.S. Food and Drug Administration has embarked on a comprehensive evaluation of cannabidiol (CBD) products, with a focus on educating the public about the risks and unknowns of these products, gathering the science needed to better understand both these safety concerns and potential benefits to inform our Read the full article…

USDA Publishes “Economic Viability Of Industrial Hemp In The United States: A Review of State Pilot Programs”

BY TYLER B. MARK, JONATHAN SHEPHERD, DAVID OLSON, WILLIAM SNELL, SUSAN PROPER, AND SUZANNE THORNSBURY After a hiatus of almost 45 years, the 2014 Farm Bill reintroduced industrial hemp production in the United States through State pilot programs. This study documents outcomes and lessons learned from the State pilot programs and examines legal, agronomic, and economic Read the full article…

FDA Warning Letters And Test Results For Cannabidiol-Related Products

DISTRICT OF COLUMBIA: Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD Read the full article…

A Guide To Using CBD For Pain Management

Cannabidiol, commonly known as CBD, is a term that’s gained quite a traction in the medical world. A substance that naturally occurs in the cannabis plant, CBD doesn’t result in the “high” that is typically linked to cannabis. In fact, the “high” feeling is a result of using tetrahydrocannabinol (THC), which is another kind of Read the full article…

Why Researchers Recommend Using CBD After A Workout

By Hannah Jones The workout is considered as trending physical activity these days. As interest continues to grow among health and fitness trends, people have begun to look for new ways to enhance their fitness regime. Perhaps, eating a lot of protein and taking pre and post workout supplements can help you make the most Read the full article…

Study: CBD Dosing Relieves Symptoms In Patients With Anxiety Disorders

COLORADO: The daily administration of CBD is associated with sustained symptomatic relief in patients diagnosed with anxiety disorders, according to the results of a case series published in The Permanente Journal. Investigators at the University of Colorado, Denver and Colorado State University assessed the adjunctive use of low daily doses of CBD (typically 25mg capsules) over a Read the full article…

Cura Partners Expands Operations To Arizona

Cura supports Arizona’s medical marijuana market and gears up for additional domestic and international expansion ARIZONA: Cura Partners, one of the largest marijuana companies in the world, known for its best-selling brands Select Oil and Select CBD, recently opened its Arizona headquarters in Phoenix, Arizona. This move signifies the company’s commitment to bringing the safest and cleanest medical marijuana products Read the full article…

FSD Pharma Announces Launch of IBS Clinical Study

CANADA: FSD Pharma has announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic R&D partner, SciCann Therapeutics. The study is designed to test the safety and efficacy of SciCann’s proprietary “Steady Stomach” cannabidiol (CBD) combination product for the treatment of irritable bowel syndrome (IBS) patients. This study follows the previously reported efficacy Read the full article…